These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 16785788)
1. GLUT-1 is preferentially expressed in atypical endometrial hyperplasia and endometrial adenocarcinoma. Ashton-Sager A; Paulino AF; Afify AM Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):187-92. PubMed ID: 16785788 [TBL] [Abstract][Full Text] [Related]
2. GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma. Canpolat T; Ersöz C; Uğuz A; Vardar MA; Altintaş A Turk Patoloji Derg; 2016; 32(3):141-7. PubMed ID: 27562387 [TBL] [Abstract][Full Text] [Related]
3. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium. Afify AM; Craig S; Paulino AF; Stern R Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159 [TBL] [Abstract][Full Text] [Related]
4. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions]. Xiong Y; Xiong YY; Zhou YF Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia. Wang BY; Kalir T; Sabo E; Sherman DE; Cohen C; Burstein DE Cancer; 2000 Jun; 88(12):2774-81. PubMed ID: 10870060 [TBL] [Abstract][Full Text] [Related]
6. Expression of Glut-1 in Normal Endometrium and Endometrial Lesions: Analysis of 336 Cases. Němejcová K; Rosmusová J; Bártů M; Důra M; Tichá I; Dundr P Int J Surg Pathol; 2017 Aug; 25(5):389-396. PubMed ID: 28381136 [TBL] [Abstract][Full Text] [Related]
7. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma. Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of CD44s and CD44v6 in endometriosis and adenomyosis : comparison with normal, hyperplastic, and malignant endometrium. Lin Z; Cho S; Jeong H; Kim H; Kim I J Korean Med Sci; 2001 Jun; 16(3):317-22. PubMed ID: 11410693 [TBL] [Abstract][Full Text] [Related]
9. [Expression of glucose transporter-1 in endometrial hyperplasia and well-differentiated endometrioid adenocarcinoma]. Liu AJ; Hou N; Chen LZ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):398-400. PubMed ID: 12940086 [TBL] [Abstract][Full Text] [Related]
10. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma. Buell-Gutbrod R; Cavallo A; Lee N; Montag A; Gwin K Int J Gynecol Pathol; 2015 Jan; 34(1):65-73. PubMed ID: 25473755 [TBL] [Abstract][Full Text] [Related]
11. Expression of nm23 in normal, hyperplastic and neoplastic endometrial tissues. Brustmann H; Naudé S Pathol Res Pract; 1999; 195(12):829-34. PubMed ID: 10631718 [TBL] [Abstract][Full Text] [Related]
12. Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma. Xiong Y; Xiong YY; Zhou YF Eur J Gynaecol Oncol; 2010; 31(2):160-4. PubMed ID: 20527231 [TBL] [Abstract][Full Text] [Related]
13. Maspin expression, subcellular localization and clinicopathological correlation in endometrial hyperplasia and endometrial adenocarcinoma. Blandamura S; Alessandrini L; Saccardi C; Giacomelli L; Fabris A; Borghero A; Litta P Histol Histopathol; 2014 Jun; 29(6):777-83. PubMed ID: 24346847 [TBL] [Abstract][Full Text] [Related]
14. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia. Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295 [TBL] [Abstract][Full Text] [Related]
15. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA. Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717 [TBL] [Abstract][Full Text] [Related]
16. Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer. Woo MM; Alkushi A; Verhage HG; Magliocco AM; Leung PC; Gilks CB; Auersperg N Clin Cancer Res; 2004 Dec; 10(23):7958-64. PubMed ID: 15585630 [TBL] [Abstract][Full Text] [Related]
17. Patterns of immunohistochemical staining for p53 expression in hyperplastic endometrium and adenocarcinoma. Terlikowski S; Lenczewski A; Famulski W; Sulkowska M; Dobrzycka B; Stasiuk-Barmuta A; Kulikowski M Folia Histochem Cytobiol; 2001; 39 Suppl 2():195-6. PubMed ID: 11820604 [TBL] [Abstract][Full Text] [Related]
18. Expression pattern of PAX2 in hyperplastic and malignant endometrium. Kahraman K; Kiremitci S; Taskin S; Kankaya D; Sertcelik A; Ortac F Arch Gynecol Obstet; 2012 Jul; 286(1):173-8. PubMed ID: 22274645 [TBL] [Abstract][Full Text] [Related]
19. Tenascin expression in normal, hyperplastic, and neoplastic endometrium. Sedele M; Karaveli S; Peştereli HE; Simşek T; Elpek G; Uner M; Sargin CF Int J Gynecol Pathol; 2002 Apr; 21(2):161-6. PubMed ID: 11917226 [TBL] [Abstract][Full Text] [Related]
20. Cathepsin D expression in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis. Mylonas I; Makovitzky J; Richter DU; Jeschke U; Briese V; Friese K Acta Histochem; 2003; 105(3):245-52. PubMed ID: 13677618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]